An uninspiring quarterly earnings report and a clutch of analyst price target cuts put Docusign (NASDAQ: DOCU) stock in the market’s doghouse in June. The first month of summer surely wasn’t the warmest for the company, as its shares lost over 12% of their value during the period.
Before the first trading week of the month was over, Docusign had unveiled its first quarter of fiscal 2026 figures. At first glance, they looked good — revenue cranked 8% higher year over year (to almost $764 million), which was an encouraging result given the company’s well-established position in its niche. That was on the back of a 4% climb in billings to just under $740 million.
Image source: Getty Images.